Totally implantable venous catheters for chemotherapy
experience in 500 patients
Keywords:
Infection, Thrombosis, Catheterization, Central venous catheterization, Drug therapyAbstract
CONTEXT: Totally implantable devices are increasingly being utilized for chemotherapy treatment of oncological patients, although few studies have been done in our environment to analyze the results obtained from the implantation and utilization of such catheters. OBJECTIVE: To study the results obtained from the implantation of totally implantable catheters in patients submitted to chemotherapy. TYPE OF STUDY: Prospective. SETTING: Hospital do Câncer A.C. Camargo, São Paulo, Brazil. METHODS: 519 totally implantable catheters were placed in 500 patients submitted to chemotherapy, with preference for the use of the right external jugular vein. Evaluations were made of the early and late-stage complications and patient evolution until removal of the device, death or the end of the treatment. RESULTS: The prospective analysis showed an average duration of 353 days for the catheters. There were 427 (82.2%) catheters with no complications. Among the early complications observed, there were 15 pathway hematomas, 8 cases of thrombophlebitis of the distal stump of the external jugular vein and one case of pocket infection. Among the late-stage complications observed, there were 43 infectious complications (0.23/1000 days of catheter use), 11 obstructions (0.06/1000 days of catheter use) and 14 cases of deep vein thrombosis (0.07/1000 days of catheter use). Removal of 101 catheters was performed: 35 due to complications and 66 upon terminating the treatment. A total of 240 patients died while the catheter was functioning and 178 patients are still making use of the catheter. CONCLUSION: The low rate of complications obtained in this study confirms the safety and convenience of the use of totally implantable accesses in patients undergoing prolonged chemotherapy regimes.
Downloads
References
Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136(4):602-6.
Hickman RO, Buckner CD, Clift RA, Sandres JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148(6):871-5.
Gyves JW, Ensminger WD, Niederhuber JE, et al. A totally implanted injection port system for blood sampling and che- motherapy administration. JAMA. 1984;251(19):2538-41.
Freytes CO, Reid P, Smith KL. Long-term experience with a totally implanted catheter system in cancer patients. J Surg Oncol. 1990;45(2):99-102.
Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Clas- sical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administra- tion: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol. 1989;25(6):939-44.
Capaccioli L, Nistri M, Distante V, Rontini M, Manetti A, Stecco A. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques]. Posiz- ionamento e gestione dei sistemi per accesso venoso centrale a lungo termine: contributo della diagnostica per immagini. Radiol Med (Torino). 1998;96(4):369-74.
Cohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies. Gynecol Oncol. 2001;83(3):533-6.
Herrmann KA, Waggershauser T, Helmberger T, Heinemann V, Sittek H, Reiser M. [Percutaneous interventional radiologic implantation of intravenous port-catheter systems]. Interven- tionell-radiologische perkutane Implantation intravenöser Port- Katheter-Systeme. Radiologe. 1999;39(9):777-82.
Campbell T. Central venous catheter management in patients with cancer. Int J Palliat Nurs. 2000;6(7):331-7.
Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE. Longterm central venous access in gynecologic cancer patients. J Am Coll Surg. 2000;191(4):403-9.
Abrahm JL, Mullen JL. A prospective study of prolonged central venous access in leukemia. JAMA. 1982;248(21):2868-73.
Costantini R, Napolitano L, Scurti D, Innocenti P. [Totally implantable central venous systems in neoplastic patients]. I sistemi venosi centrali totalmente impiantabili nei pazienti neoplastici. Ann Ital Chir. 1997;68(3):357-60.
Jaeger K, Osthaus A, Heine J, et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent cath- eter-associated infection in cancer patients. Chemotherapy. 2001;47(1):50-5.
Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin pro- phylaxis for central venous catheter insertion in cancer patients. J Hosp Infect. 1990;15(1):95-102.
Ballarini C, Intra M, Pisani Ceretti A, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology. 1999;56(2):97-102.
Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol. 1999;20(3):187-91.
Douard MC, Ardoin C, Payri L, Tarot JP. [Infectious complica- tions of long term intravenous devices: incidence, risk factors, diagnostic tools]. Complications infectieuses des dispositifs intraveineux de longue durée: incidence, facteurs de risque, moyens diagnostiques. Pathol Biol (Paris). 1999;47(3):288-91.
Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter- related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet. 1999;354(9184):1071-7.
Groebli Y, Bartolomei J, Wuthrich P, Callewaert G, Tschantz P, Piguet D. [Post-mortem evaluation following oncologic treatment of the functional and bacteriologic status of 25 per- manent venous access devices]. Evaluation post-mortem après traitement oncologique de l’état fonctionnel et bactériologique de 25 accès veineux permanents. Schweiz Med Wochenschr. 1998;128(36):1334-8.
Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular cath- eters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168(2):400-7.
Astagneau P, Maugat S, Tran-Minh T, et al. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol. 1999;20(7):494-8.
Kappers-Klunne MC, Degener JE, Stijnen T, Abels J. Compli- cations from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer. 1989;64(8):1747-52.
Hanna HA, Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol. 2001;22(3):165-6.
Balestreri L, De Cicco M, Matovic M, Coran F, Morassut S. Central venous catheter-related thrombosis in clinically asymp- tomatic oncologic patients: a phlebographic study. Eur J Radiol. 1995;20(2):108-11.
Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian venous thrombosis. Am J Med. 1993;95(4):419-23.
Pintor Holguín E, Sáez Noguero F, Piret Ceballos MV, et al. [Axillary-subclavian thrombosis: review of its etiology and features in recent years]. Trombosis axilosubclavia: revisión de la etiología y características en los últimos años. An Med Interna. 1997;14(2):67-70.
De Cicco M, Matovic M, Balestreri L, et al . Central venous thrombosis: an early and frequent complication in cancer pa- tients bearing long-term silastic catheter. A prospective study. Thromb Res. 1997;86(2):101-13.
Conlan MG, Haire WD, Lieberman RP, Lund G, Kessinger A, Armitage JO. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell trans- plantation. Bone Marrow Transplant. 1991;7(3):235-40.
Monreal M, Davant E. Thrombotic complications of central venous catheters in cancer patients. Acta Haematol. 2001;106(1-2):69-72.
Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complica- tions of central venous catheters. JAMA. 1994;271(13):1014-6.
Rodenhuis S, van’t Hek LG, Vlasveld LT, Kroger R, Dubbelman R, van Tol RG. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator. Thorax. 1993;48(5):558-9.
Bothe A, Piccione W, Ambrosino JJ, Benotti PN, Lokich JJ. Implantable central venous access system. Am J Surg. 1984;147(4):565-9.
Lokich JJ, Bothe A, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol. 1985;3(5):710-7.
Harvey WH, Pick TE, Reed K, Solenberger RI. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet. 1989;169(6):495-500.
Torramadé JR, Cienfuegos JA, Hernández JL, et al. The compli- cations of central venous access systems: a study of 218 patients. Eur J Surg. 1993;159(6-7):323-7.
Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nolè F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyz- ing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998;9(7):767-73.
